JP2000159790A5 - - Google Patents

Download PDF

Info

Publication number
JP2000159790A5
JP2000159790A5 JP1999331141A JP33114199A JP2000159790A5 JP 2000159790 A5 JP2000159790 A5 JP 2000159790A5 JP 1999331141 A JP1999331141 A JP 1999331141A JP 33114199 A JP33114199 A JP 33114199A JP 2000159790 A5 JP2000159790 A5 JP 2000159790A5
Authority
JP
Japan
Prior art keywords
antibiotic drug
compound
formula
pharmaceutically acceptable
acid addition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1999331141A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000159790A (ja
Filing date
Publication date
Priority claimed from FR9814782A external-priority patent/FR2786188B1/fr
Application filed filed Critical
Publication of JP2000159790A publication Critical patent/JP2000159790A/ja
Publication of JP2000159790A5 publication Critical patent/JP2000159790A5/ja
Pending legal-status Critical Current

Links

JP11331141A 1998-11-24 1999-11-22 新規のエリスロマイシン誘導体、それらの製造方法及びそれらの薬剤としての使用 Pending JP2000159790A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9814782 1998-11-24
FR9814782A FR2786188B1 (fr) 1998-11-24 1998-11-24 Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments

Publications (2)

Publication Number Publication Date
JP2000159790A JP2000159790A (ja) 2000-06-13
JP2000159790A5 true JP2000159790A5 (enExample) 2006-12-07

Family

ID=9533122

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11331141A Pending JP2000159790A (ja) 1998-11-24 1999-11-22 新規のエリスロマイシン誘導体、それらの製造方法及びそれらの薬剤としての使用

Country Status (24)

Country Link
US (2) US6440941B1 (enExample)
EP (1) EP1004592B1 (enExample)
JP (1) JP2000159790A (enExample)
KR (1) KR100587445B1 (enExample)
CN (1) CN1165546C (enExample)
AR (1) AR021388A1 (enExample)
AT (1) ATE245160T1 (enExample)
AU (1) AU772171B2 (enExample)
BR (1) BR9905735A (enExample)
CA (1) CA2290136C (enExample)
DE (1) DE69909577T2 (enExample)
DK (1) DK1004592T3 (enExample)
ES (1) ES2198867T3 (enExample)
FR (1) FR2786188B1 (enExample)
HU (1) HUP9904392A3 (enExample)
IL (1) IL133101A (enExample)
MX (1) MXPA99010813A (enExample)
NO (1) NO314729B1 (enExample)
PL (1) PL336736A1 (enExample)
PT (1) PT1004592E (enExample)
RU (1) RU2237672C2 (enExample)
TR (1) TR199902888A3 (enExample)
TW (1) TWI247747B (enExample)
ZA (1) ZA997176B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
DK1147121T3 (da) * 1999-01-27 2004-04-13 Pfizer Prod Inc Ketolidantibiotika
EE200100613A (et) 1999-05-24 2003-02-17 Pfizer Products Inc. 13-metüülerütromütsiini derivaadid
EP1167376B1 (en) 2000-06-30 2004-07-14 Pfizer Products Inc. Macrolide antibiotics
US7601695B2 (en) 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
FR2862647B1 (fr) * 2003-11-25 2008-07-04 Aventis Pharma Sa Derives de pyrazolyle, procede de preparation et intermediaires de ce procede a titre de medicaments et de compositions pharmaceutiques les renfermant
WO2006080954A1 (en) * 2004-07-28 2006-08-03 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
AU2008316830B2 (en) 2007-10-25 2016-03-17 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
US8552162B2 (en) * 2008-05-09 2013-10-08 Enanta Pharmaceuticals, Inc. Processes for the preparation of 2 fluoro 6-11 bicyclic erythromycin derivatives
CN107854477A (zh) 2008-10-24 2018-03-30 森普拉制药公司 使用含三唑的大环内酯治疗抗性疾病的方法
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US9480679B2 (en) 2009-09-10 2016-11-01 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
HRP20160168T1 (hr) 2010-03-22 2016-03-25 Cempra Pharmaceuticals Inc Kristalne forme makrolida i njihova uporaba
BR112012029586A2 (pt) 2010-05-20 2016-08-02 Cempra Pharmaceuticals Inc processos para preparar macrolídeos e cetolídeos e intermediários dos mesmos
KR20130120458A (ko) * 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
BR112013009823A2 (pt) 2010-10-22 2016-07-05 Bayer Ip Gmbh novos compostos heterocíclicos como pesticidas
WO2013148891A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
WO2014152326A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
AU2014233240B2 (en) 2013-03-15 2018-08-09 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
CN106432383A (zh) * 2016-09-14 2017-02-22 重庆两江药物研发中心有限公司 索利霉素及其中间体的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4182895A (en) * 1976-12-20 1980-01-08 Sterling Drug Inc. 1-Amino-lower-alkyl-3,4-diphenyl-1H-pyrazoles
CA1098527A (en) * 1976-12-20 1981-03-31 Denis M. Bailey 1-amino-lower-alkyl-3,4-diphenyl-1h-pyrazoles
JPH04234891A (ja) * 1990-03-05 1992-08-24 Fujisawa Pharmaceut Co Ltd 新規セフェム化合物およびその塩
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
KR20010013660A (ko) * 1997-06-11 2001-02-26 실버스타인 아써 에이. 9-옥심 에리트로마이신 유도체
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments

Similar Documents

Publication Publication Date Title
JP2002511411A5 (enExample)
CA2386690A1 (en) Pharmaceutical tramadol salts
WO2003037860A3 (en) Purine analogs having hsp90-inhibiting activity
CA2382919A1 (en) Bicyclic imidazo-3-yl-amine derivatives
RU95101048A (ru) Производные пролинамида, фармкомпозиция на их основе
EP1659111A3 (en) Piperidine derivatives useful as ccr5 antagonists
BRPI0015567B8 (pt) composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica
TNSN04213A1 (en) High drug load tablet
EP1076055A4 (en) 1- (1-SUBST.-4-PIPERIDINYL) METHYL] -4-PIPERIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL MIXTURES AND INTERMEDIATES FOR THE PRODUCTION THEREOF
CA2326222A1 (en) Medicinal compositions
CA2005986A1 (en) Benzimidazole derivative with gastric acid inhibitory effect and process for its preparation
RU2002100058A (ru) Кристаллические производные 1-метилкарбапенема
CA2336412A1 (en) Medicament for treatment of diabetes
SE0300908D0 (sv) Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
WO2001027110A3 (de) Am sechsring substituierte, bicyclische imidazo-3-yl-aminderivate
NO20013060L (no) Kontrollert frigjörende farmasöytisk preparat med tilidinmesylat som virkestoff
CA2393757A1 (en) Cycloamine ccr5 receptor antagonists
CA2489140A1 (en) Dosage form containing pantoprazole as active ingredient
CA2494321A1 (en) 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
EP1426360A4 (en) 2-PHENYL-3-HETEROARYLPROPIONIC ACID DERIVATIVE OR SALT THEREOF AND MEDICAMENTS CONTAINING THE SAME
CA2005980A1 (en) Benzimidazole derivative with gastric acid inhibitory effect and process for its preparation
EP1219296A4 (en) MEANS TO INHIBIT SEBUM PRODUCTION
EP1149832A4 (en) BENZAMIDE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THEM
CA2373962A1 (en) Immediate release medicinal compositions for oral use
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents